CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsHigh structural barrier to entry
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.04BUSDvs all stocks (USD)
Revenue (TTM)
159.54MUSDvs all stocks (USD)
Profit Margin
-1.14%Beta
1.24xvs all stocks
52-Week Change
33.49%vs all stocks
Market Capitalization
1.04BUSDvs all stocks (USD)
Enterprise Value
253.44MUSDvs all stocks (USD)
Forward P/E
-68.75xPrice to Sales (TTM)
6.44xPrice to Book (MRQ)
0.9636xEnterprise to Revenue
1.59xGross Margin
42.36%Profit Margin
-1.14%Operating Margin
-1.10%Return on Assets (TTM)
-0.78%Return on Equity (TTM)
0.45%Revenue (TTM)
159.54MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.4170USDUpdated Jul 18, 2026Quarterly Revenue Growth
40.10%Gross Profit (TTM)
63.20MUSDvs all stocks (USD)
EBITDA (TTM)
32.08MUSDvs all stocks (USD)
Net Income (TTM)
-1.82MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
124.60%Operating Cash Flow (TTM)
38.86MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-15.45MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
49.06MUSDFY2025 · Dec 31, 2025Revenue
146.59MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
83.83MUSDFY2025 · Dec 31, 2025Gross Profit
62.76MUSDFY2025 · Dec 31, 2025Operating Income
-19.50MUSDvs all stocks (USD)
Pre-tax Income
-17.12MUSDFY2025 · Dec 31, 2025Income Tax Expense
-14.19MUSDFY2025 · Dec 31, 2025Net Income
-2.93MUSDFY2025 · Dec 31, 2025EBIT
-19.50MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
32.08MUSDFY2025 · Dec 31, 2025Research & Development
4.45MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
70.81MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
39.96MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
383.47MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
383.47MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-2.93MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-6.52MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-14.92MUSDFY2025 · Dec 31, 2025Free Cash Flow
-40.64MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
791.79MUSDFY2025 · Dec 31, 2025Income Tax Paid
104.00KUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-2.93MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
14.23MUSDFY2025 · Dec 31, 2025Stock-based Compensation
7.05MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.77MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-25.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.11MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-10.39MUSDFY2025 · Dec 31, 2025Capital Expenditures
-25.72MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-339.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-45.11MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
-5.40MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-76.22MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-9.74MUSDFY2025 · Dec 31, 2025Other Financing Charges
-10.16MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-19.91MUSDFY2025 · Dec 31, 2025Shares Outstanding
376.26MSharesUpdated Jul 18, 2026Float Shares
192.24MSharesUpdated Jul 18, 2026Shares Short
3.14MSharesUpdated Jul 18, 2026Short Ratio
2.81daysvs all stocks
Short % of Shares Outstanding
1.67%vs all stocks
% Held by Insiders
48.55%vs all stocks
% Held by Institutions
15.64%vs all stocks
Total Cash (MRQ)
821.86MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.20USDUpdated Jul 18, 2026Total Debt (MRQ)
1.31MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0012xCurrent Ratio (MRQ)
21.87xBook Value per Share (MRQ)
2.85USDUpdated Jul 18, 2026Total Assets
1.20BUSDvs all stocks (USD)
Total Current Assets
944.09MUSDFY2025 · Dec 31, 2025Total Liabilities
54.18MUSDFY2025 · Dec 31, 2025Total Non-current Assets
253.05MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
5.99MUSDFY2025 · Dec 31, 2025Total Current Liabilities
48.19MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
791.79MUSDFY2025 · Dec 31, 2025Other Short-term Investments
40.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
34.10MUSDFY2025 · Dec 31, 2025Inventory
46.75MUSDFY2025 · Dec 31, 2025Accounts Payable
11.64MUSDFY2025 · Dec 31, 2025Short-term Debt
337.00KUSDFY2025 · Dec 31, 2025Long-term Debt
1.17MUSDFY2025 · Dec 31, 2025Common Stock (Book)
662.98MUSDFY2025 · Dec 31, 2025Retained Earnings
447.76MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.14BUSDvs all stocks (USD)
52-Week Low
1.93USDUpdated Jul 18, 202652-Week High
3.43USDUpdated Jul 18, 202652-Week Change
33.49%vs all stocks
Beta
1.24xvs all stocks
50-Day MA
2.72USDUpdated Jul 18, 2026200-Day MA
2.63USDUpdated Jul 18, 2026Avg 10-Day Volume
652.02KSharesUpdated Jul 18, 2026Avg 30-Day Volume
987.11KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.0200USDUpdated Jul 18, 2026Other Income / Expense
-37.59MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.42Profit Margin: -0.01
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.82
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Medincell SA
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Animal Husbandry Industry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Highfine Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CK Life Sciences Int'l.,
Tier 1ProductionApproval-Gated PipelineFlowInterface
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Happy Forgings Ltd
1 interpretationOperating Income Growing With Multi-Year Revenue Growth
JCHX Mining Management Co., Ltd.
1 interpretationOperating Income Growing With Multi-Year Revenue Growth
Distribution Solutions Group, Inc.
1 interpretationOperating Income Growing With Multi-Year Revenue Growth